Ftse Mib
34.258,93
-0,34%
DAX
18.470,38
-0,70%
S&P 500
5.649,34
0,32%
NASDAQ
18.553,63
0,44%
Bitcoin
63.574,99
-1,97%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Motif Bio Plc (MTFB) Motif Bio Plc (MTFB) Notizie

MTFB

Motif Bio (MTFB)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:MTFB
DataOraFonteTitoloSimboloCompagnia
15/12/201508:00UK RegulatoryMotif Bio PLC Iclaprim Clinical Trial Supplies ManufacturedLSE:MTFBMotif Bio Plc
07/12/201508:00RNS Non-RegulatoryMotif Bio PLC Motif selected to present at Biotech ShowcaseLSE:MTFBMotif Bio Plc
24/11/201513:40Alliance NewsAlliance NewsMotif Bio Gets US FDA Agreement For Iclaprim Trial DoseLSE:MTFBMotif Bio Plc
24/11/201508:01UK RegulatoryMotif Bio PLC Receipt of FDA ConcurrenceLSE:MTFBMotif Bio Plc
11/11/201511:58Alliance NewsAlliance NewsMotif Bio Gets Advice On Iclaprim Regulatory ProcessLSE:MTFBMotif Bio Plc
11/11/201508:01UK RegulatoryMotif Bio PLC European Agreement for Iclaprim DevelopmentLSE:MTFBMotif Bio Plc
27/10/201508:00RNS Non-RegulatoryMotif Bio PLC Selected to Present at BIO-Europe 2015LSE:MTFBMotif Bio Plc
21/10/201508:00UK RegulatoryMotif Bio PLC Exercise of OptionsLSE:MTFBMotif Bio Plc
16/10/201509:14Alliance NewsAlliance NewsMotif Bio Signs Clinical Trials Deal With Covance For IclaprimLSE:MTFBMotif Bio Plc
16/10/201508:00UK RegulatoryMotif Bio PLC Leading CRO to Conduct Iclaprim Phase III TrialsLSE:MTFBMotif Bio Plc
13/10/201510:13Alliance NewsAlliance NewsMotif Bio Says Iclaprim Study Data Shown At Infectious Disease WeekLSE:MTFBMotif Bio Plc
13/10/201508:00RNS Non-RegulatoryMotif Bio PLC Results of Two Posters on Iclaprim at ID Week 2015LSE:MTFBMotif Bio Plc
12/10/201517:05Alliance NewsAlliance NewsMotif Bio Issues 53,887 Shares To Former Director (ALLISS)LSE:MTFBMotif Bio Plc
05/10/201517:41UK RegulatoryMotif Bio PLC Directors DealingsLSE:MTFBMotif Bio Plc
29/09/201514:05Alliance NewsAlliance NewsMotif Bio To Present Data From Two Iclaprim Studies At ConferenceLSE:MTFBMotif Bio Plc
29/09/201508:02RNS Non-RegulatoryMotif Bio PLC Presentation of Two Posters on IclaprimLSE:MTFBMotif Bio Plc
23/09/201516:04UK RegulatoryMotif Bio PLC Issue of Shares for Exercised WarrantsLSE:MTFBMotif Bio Plc
03/09/201509:04Alliance NewsAlliance NewsMotif Bio Gets US Fast Track Designation For Iclaprim TreatmentLSE:MTFBMotif Bio Plc
03/09/201508:00UK RegulatoryMotif Bio PLC FDA Grants Fast Track Designation for IclaprimLSE:MTFBMotif Bio Plc
02/09/201508:00RNS Non-RegulatoryMotif Bio PLC Appointment of IR AdviserLSE:MTFBMotif Bio Plc
02/09/201508:00RNS Non-RegulatoryMotif Bio PLC Participation at Upcoming Investor EventsLSE:MTFBMotif Bio Plc
27/08/201511:07Alliance NewsAlliance NewsMotif Bio Loss Widens In Maiden Interim ResultsLSE:MTFBMotif Bio Plc
27/08/201508:03UK RegulatoryMotif Bio PLC Interims Results for the 6 months to 30 June 2015LSE:MTFBMotif Bio Plc
24/08/201510:56Alliance NewsAlliance NewsMotif Bio Says Report Shows "Encouraging" Results For IclaprimLSE:MTFBMotif Bio Plc
24/08/201508:00UK RegulatoryMotif Bio PLC Potent Efficacy of Iclaprim ConfirmedLSE:MTFBMotif Bio Plc
22/07/201517:32UK RegulatoryMotif Bio PLC FDA QIDP DesignationLSE:MTFBMotif Bio Plc
22/07/201510:08Alliance NewsAlliance NewsMotif Bio Says Final Condition For GBP22 Million Placing Satisfied (ALLISS)LSE:MTFBMotif Bio Plc
22/07/201508:00UK RegulatoryMotif Bio PLC Final condition of £22m placing satisfiedLSE:MTFBMotif Bio Plc
17/07/201508:40Alliance NewsAlliance NewsMotif Bio's Iclaprim Eligible For Incentives With New US DesignationLSE:MTFBMotif Bio Plc
17/07/201508:00UK RegulatoryMotif Bio PLC FDA QIDP Designation for Iclaprim for HABPLSE:MTFBMotif Bio Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:MTFB

La tua Cronologia

LSE
TOPE
NASDAQ
ADI
Analog Devices
LSE
MXFS
Inv Msci Emerg
LSE
ROLL
Is Bg Rl Cmt-u
NASDAQ
INTC
Intel
NASDAQ
NTLA
Intellia Therapeutics
NASDAQ
FARO
FARO Technologies
NYSE
HMN
Horace Mann Educators
LSE
VTY
Vistry
NYSE
BNED
Barnes and Noble Education
LSE
ITPA
Ishs$tips Hacc
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network